CSPC Innovation Pharmaceutical Co Ltd Class A (300765) — Cash Flow Quality Index
CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has a Cash Flow Quality Index of -2.69x as of June 2025. Operating cash flow of CN¥-65.01 Million is below net income of CN¥24.16 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of CSPC Innovation Pharmaceutical Co Ltd Cl to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CSPC Innovation Pharmaceutical Co Ltd Class A Cash Flow Quality Index (2014–2023)
Historical Cash Flow Quality Index for CSPC Innovation Pharmaceutical Co Ltd Class A across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 300765 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for CSPC Innovation Pharmaceutical Co Ltd Class A (2014–2023)
Year-by-year earnings quality comparison for CSPC Innovation Pharmaceutical Co Ltd Class A. For live market cap and the full company financial profile, see CSPC Innovation Pharmaceutical Co Ltd Cl stock valuation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 1.23x | CN¥927.24 Million | CN¥755.56 Million | ▲ +39.2% |
| 2022 | 0.88x | CN¥640.72 Million | CN¥726.61 Million | ▲ +18.6% |
| 2021 | 0.74x | CN¥292.09 Million | CN¥392.70 Million | ▼ -36.1% |
| 2020 | 1.16x | CN¥349.07 Million | CN¥299.71 Million | ▲ +1.0% |
| 2019 | 1.15x | CN¥315.38 Million | CN¥273.53 Million | ▲ +61.9% |
| 2018 | 0.71x | CN¥159.73 Million | CN¥224.32 Million | ▲ +10574.1% |
| 2017 | 0.01x | CN¥1.30 Million | CN¥194.91 Million | ▼ -99.0% |
| 2016 | 0.67x | CN¥137.27 Million | CN¥206.36 Million | ▼ -31.4% |
| 2015 | 0.97x | CN¥112.05 Million | CN¥115.48 Million | ▲ +12.5% |
| 2014 | 0.86x | CN¥93.36 Million | CN¥108.24 Million | — |